JP2023550902A5 - - Google Patents

Info

Publication number
JP2023550902A5
JP2023550902A5 JP2023527318A JP2023527318A JP2023550902A5 JP 2023550902 A5 JP2023550902 A5 JP 2023550902A5 JP 2023527318 A JP2023527318 A JP 2023527318A JP 2023527318 A JP2023527318 A JP 2023527318A JP 2023550902 A5 JP2023550902 A5 JP 2023550902A5
Authority
JP
Japan
Prior art keywords
methyl
compound according
hydroxymethyl
indazol
thiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023527318A
Other languages
English (en)
Japanese (ja)
Other versions
JP7840327B2 (ja
JP2023550902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/083279 external-priority patent/WO2022117477A1/en
Publication of JP2023550902A publication Critical patent/JP2023550902A/ja
Publication of JP2023550902A5 publication Critical patent/JP2023550902A5/ja
Application granted granted Critical
Publication of JP7840327B2 publication Critical patent/JP7840327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023527318A 2020-12-01 2021-11-29 新規インダゾールアセチレン誘導体 Active JP7840327B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20210859 2020-12-01
EP20210859.3 2020-12-01
PCT/EP2021/083279 WO2022117477A1 (en) 2020-12-01 2021-11-29 New indazole acetylene derivatives

Publications (3)

Publication Number Publication Date
JP2023550902A JP2023550902A (ja) 2023-12-06
JP2023550902A5 true JP2023550902A5 (enExample) 2024-12-04
JP7840327B2 JP7840327B2 (ja) 2026-04-03

Family

ID=73654642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527318A Active JP7840327B2 (ja) 2020-12-01 2021-11-29 新規インダゾールアセチレン誘導体

Country Status (16)

Country Link
US (1) US20240002390A1 (enExample)
EP (1) EP4255908A1 (enExample)
JP (1) JP7840327B2 (enExample)
KR (1) KR20230116799A (enExample)
CN (1) CN116490182A (enExample)
AR (1) AR124170A1 (enExample)
AU (1) AU2021393722A1 (enExample)
CA (1) CA3197659A1 (enExample)
CL (1) CL2023001440A1 (enExample)
CO (1) CO2023006912A2 (enExample)
CR (1) CR20230218A (enExample)
IL (1) IL303064A (enExample)
MX (1) MX2023006176A (enExample)
PE (1) PE20240099A1 (enExample)
TW (1) TWI915460B (enExample)
WO (1) WO2022117477A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254565A1 (en) 2019-06-21 2020-12-24 F. Hoffmann-La Roche Ag Egfr inhibitors for the treatment of cancer
WO2022117475A1 (en) 2020-12-01 2022-06-09 F. Hoffmann-La Roche Ag New indazole derivatives
US20260007678A1 (en) * 2022-05-13 2026-01-08 Hoffmann-La Roche Inc. Combination of allosteric and orthosteric egfr inhibitors for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2987914C (en) 2015-06-30 2022-09-13 Dana-Farber Cancer Institute, Inc. Inhibitors of egfr and methods of use thereof
TW201834651A (zh) * 2016-12-22 2018-10-01 瑞士商赫孚孟拉羅股份公司 化合物
AR113299A1 (es) 2017-06-02 2020-04-08 Hoffmann La Roche Compuestos de isoindolina
CA3103166A1 (en) * 2018-06-29 2020-01-02 F. Hoffmann-La Roche Ag Compounds
AR121167A1 (es) 2019-06-21 2022-04-27 Hoffmann La Roche DERIVADOS DE PIRROLO[1,2-c]IMIDAZOL COMO INHIBIDORES DE EGFR

Similar Documents

Publication Publication Date Title
US20220241261A1 (en) Combinations of inhibitors of irak4 with inhibitors of btk
JP5450434B2 (ja) 関節炎の治療方法
JP2014513110A5 (enExample)
JP2020510015A5 (enExample)
JP2011500758A5 (enExample)
US20210128723A1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
JP2008500992A5 (enExample)
JP2013501749A5 (enExample)
JP2011509309A5 (enExample)
JP2012503018A5 (enExample)
JP2018534288A5 (enExample)
MX2010012290A (es) Combinaciones de inhibidores del receptor del factor de crecimiento endotelial vascular e inhibidores del factor de crecimiento de hepatocito para el tratamiento de cancer.
JP2006504658A5 (enExample)
CA2493225A1 (en) Quinoline derivatives and their use as mycobacterial inhibitors
JP2022500402A5 (enExample)
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
JP2022017461A5 (enExample)
JP2012513398A5 (enExample)
JP2025506382A5 (enExample)
JP2022521380A5 (enExample)
KR20260008165A (ko) 헤테로시클릭 단백질 키나제 억제제를 포함하는 제제
JP2025516543A5 (enExample)
JP2007514790A5 (enExample)
JP2015524835A5 (enExample)
JP2022521474A5 (enExample)